HYPOCALCAEMIA: CAUSES, DIAGNOSTICS AND TREATMENT
Abstract
Hypocalcaemia is a state with total calcium serum level below 2.25 mM/l. From the total serum calcium content, 50% is free and ionized, 40% is protein-bound and 10% is bound for organic anions.
The most frequent causes of hypocalcaemia are iatrogenic hypoparathyroidism, magnesium deficit, disorders of vitamin D metabolism and chronic renal failure. Iatrogenic hypoparathyroidism is associated with low serum ionized calcium and low serum parathormone levels. There are two important clinical signs of hypocalcemia: Chvostek’s sign (twitches of upper lip after percussion on facial nerve over mandible) and Trousseau’s sign (carpal spasm after increasing pressure in blood pressure cuff placed about the upper arm for 20 milimeters above systolic pressure for 3-5 minutes).
The following lab analyses should be performed when hypocalcaemia is an option: serum levels of calcium, magnesium, 25 – hydroxyvitamin, parathormone, potassium, sodium, chloride and bicarbonates.
If hypocalcaemia is mild, it could be treated with oral calcium preparations, usually calcium carbonate, in a dose of 1 to 2 grams of elemental calcium daily. In more severe hypocalcaemia intravenous calcium-gluconate or calcium-chloride should be administered, as 10% solutions. These parenteral preparations of calcium should be diluted prior to the intravenous administration, and the administration should be longer than 20 minutes in order to avoid adverse effects on heart.
If administration of calcium does not correct hypocalcaemia, oral vitamin D should be also prescribed. If this does not regulate calcaemia, from 0.25 tо 1 micrograms of 1,25-dihydroxyvitamin D (clacitriol) daily should be prescribed. Calcium serum levels should be kept within the lower part of normal serum concentration range.References
Cooper MS, Gittoes NJ. Diagnosis and management of hypocalcaemia. BMJ 2008; 336(7656): 1298-302.
Vierucci F, Del Pistoia M, Fanos M, Erba P, Saggese G. Prevalence of hypovitaminosis D and predictors of vitamin D status in Italian healthy adolescents. Ital J Pediatr 2014; 40: 54.
El-Sherif N, Turitto G. Electrolyte disorders and arrhy-thmogenesis. Cardiol J 2011; 18(3): 233-45.
Edafe O, Antakia R, Laskar N, Uttley L, Balasubrama-nian SP. Systematic review and meta-analysis of predictors of post-thyroidectomy hypocalcaemia. Br J Surg 2014; 101(4): 307-20.
Edafe O, Prasad P, Harrison BJ, Balasubramanian SP. Incidence and predictors of post-thyroidectomy hypo-calcaemia in a tertiary endocrine surgical unit. Ann R Coll Surg Engl 2014; 96(3): 219-23.
Yamamoto M, Yamaguchi T, Yamauchi M, Yano S, Sugimoto T. Acute-onset hypomagnesemia-induced hypocalcemia caused by the refractoriness of bones and renal tubules to parathyroid hormone. J Bone Mi-ner Metab 2011; 29(6): 752-5.
Hannan FM, Thakker RV. Investigating hypocalcae-mia. BMJ 2013; 346: f2213.
Liamis G, Milionis HJ, Elisaf M. A review of drug-induced hypocalcemia. J Bone Miner Metab 2009; 27 (6): 635-42.
Fong J, Khan A. Hypocalcemia: updates in diagnosis and management for primary care. Can Fam Physician 2012; 58(2): 158-62.
Geibel JP. The calcium-sensing receptor. J Nephrol 2010; 23 Suppl 16: S130-5.
Alfadda TI, Saleh AM, Houillier P, Geibel JP. Cal-cium-Sensing Receptor 20 years later. Am J Physiol Cell Physiol. 2014 May 28. pii: ajpcell.00139.2014. [Epub ahead of print]
Forsythe RM, Wessel CB, Billiar TR, Angus DC, Rosengart MR. Parenteral calcium for intensive care unit patients. Cochrane Database Syst Rev. 2008; 4: CD006163.
Сажетак карактеристика лека. Kalcijum karbonat Alkaloid, таблете; 1 g,. Агенција за лекове и медицинска средства Србије. 2013. јануар. [cited 2014 Jul 8]. Преузето са: http://www.alims.gov.rs/ ciril/files/lekovi/smpc/515-01-5297-12-001.pdf.
Summary of Product Characteristics, Ergocalciferol Injection BP 300, 000U. London, UK: Medicines and Healthcare Products Regulatory Agency. 2014. [cited 2014 Jul 8]. Preuzeto sa: http://www.mhra.gov.uk/ home/groups/spcpil/documents/spcpil/con1369375879798.pdf.